131 related articles for article (PubMed ID: 2074058)
1. [Clinical use of alpha-interferon in onco-hematology: conclusions and prospects].
Bernasconi C
Haematologica; 1990; 75 Suppl 4():82-4. PubMed ID: 2074058
[No Abstract] [Full Text] [Related]
2. [Interferons in cancerology. Focus in 1988].
Boiron M
Pathol Biol (Paris); 1989 Feb; 37(2):92-3. PubMed ID: 2652080
[No Abstract] [Full Text] [Related]
3. Clinical use of interferon alfa-2b (intron-A): the Manchester experience.
Scarffe JH; Wagstaff J; Crowther D
Ann Ist Super Sanita; 1987; 23(4):777-8. PubMed ID: 3452285
[No Abstract] [Full Text] [Related]
4. [Effects of interferon on various malignancies].
Taguchi T
Gan To Kagaku Ryoho; 1984 Feb; 11(2):194-204. PubMed ID: 6696457
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha: current status and future promise.
Bonnem EM; Spiegel RJ
J Biol Response Mod; 1984 Dec; 3(6):580-98. PubMed ID: 6392483
[No Abstract] [Full Text] [Related]
6. [Clinical and immunological studies of human fibroblast interferon and human lymphoblastoid interferon in malignant diseases].
Ezaki K
Gan No Rinsho; 1983 May; 29(6):598-602. PubMed ID: 6308306
[No Abstract] [Full Text] [Related]
7. [Interferons: Clinical applications in hematology].
Ben Rhomdhane N; Ben Ahmed M; Zitouni M; Mtimet B
Tunis Med; 1998 Dec; 76(12):427-36. PubMed ID: 10093482
[No Abstract] [Full Text] [Related]
8. Biotherapy with interferon in hematologic malignancies.
Roth MS; Foon KA
Oncol Nurs Forum; 1987; 14(6 Suppl):16-22. PubMed ID: 2447569
[No Abstract] [Full Text] [Related]
9. Alpha-interferon in the treatment of malignant lymphoma.
Cavalli F
Br J Clin Pract Suppl; 1988 Mar; 62():16-21. PubMed ID: 3145009
[No Abstract] [Full Text] [Related]
10. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1990; 11():321-42. PubMed ID: 2223398
[No Abstract] [Full Text] [Related]
11. Beta interferon in the treatment of mycosis fungoides.
Zinzani PL; Mazza P; Gherlinzoni F
Haematologica; 1988; 73(6):547-8. PubMed ID: 3148521
[No Abstract] [Full Text] [Related]
12. INTRON A (interferon alfa-2b): clinical overview.
Spiegel RJ
Cancer Treat Rev; 1985 Dec; 12 Suppl B():5-16. PubMed ID: 3914355
[No Abstract] [Full Text] [Related]
13. [Clinical efficacy of interferon-beta (MR-21) in hematological malignancies].
Imamura Y
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):934-41. PubMed ID: 3694002
[No Abstract] [Full Text] [Related]
14. [Alpha-interferon and myelodysplastic syndromes].
Alessandrino EP; Lazzarino M; Morra E; Bernasconi P; Colombo A; Bonfichi M; Caldera D; Bernasconi C
Haematologica; 1990; 75 Suppl 4():51-5. PubMed ID: 2074055
[No Abstract] [Full Text] [Related]
15. [Gamma interferon therapy of cancer patients].
Kobayashi Y; Urabe A
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):804-9. PubMed ID: 3133983
[TBL] [Abstract][Full Text] [Related]
16. DLI or second transplant.
Greinix HT
Ann Hematol; 2002; 81 Suppl 2():S34-5. PubMed ID: 12611068
[TBL] [Abstract][Full Text] [Related]
17. Alpha-interferon treatment of cutaneous T cell lymphoma and chronic lymphocytic leukemia.
Foon KA; Bunn PA
Semin Oncol; 1986 Dec; 13(4 Suppl 5):35-9. PubMed ID: 3541217
[TBL] [Abstract][Full Text] [Related]
18. [Aspects of molecular remission in hematology and oncology].
Novik AA; Kamilova TA; Tsygan VN
Vopr Onkol; 2001; 47(3):270-7. PubMed ID: 11544823
[No Abstract] [Full Text] [Related]
19. 2nd International Congress on Leukemia, Lymphoma and Myeloma.
Arat M; Ozsan GH; Yenerel MN; Cetin M; Ozcan M
Expert Rev Hematol; 2009 Oct; 2(5):509-12. PubMed ID: 21083016
[TBL] [Abstract][Full Text] [Related]
20. Adoptive immunotherapy in human and canine chimeras--the role of interferon alfa. EBMT Chronic Leukemia Working Party.
Kolb HJ; Mittermüller J; Hertenstein H; Schumm M; Holler E; de Witte T; Günther W; Ljungman P; Goldman JM
Semin Hematol; 1993 Jul; 30(3 Suppl 3):37-9. PubMed ID: 8235705
[No Abstract] [Full Text] [Related]
[Next] [New Search]